2003
DOI: 10.1046/j.1443-9506.2003.01909.x
|View full text |Cite
|
Sign up to set email alerts
|

The atherosclerosis and folic acid supplementation trial in patients with chronic renal failure (ASFAST): baseline results

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2004
2004
2004
2004

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Carotid artery intima-media thickness (IMT) is an established surrogate marker of cardiovascular risk in elderly populations [10], and at all ages is greater in chronic renal failure patients than control patients [11]. This study examined the hypothesis that these markers would improve after successful renal transplantation, in parallel with the improved prognosis from cardiovascular disease.…”
mentioning
confidence: 99%
“…Carotid artery intima-media thickness (IMT) is an established surrogate marker of cardiovascular risk in elderly populations [10], and at all ages is greater in chronic renal failure patients than control patients [11]. This study examined the hypothesis that these markers would improve after successful renal transplantation, in parallel with the improved prognosis from cardiovascular disease.…”
mentioning
confidence: 99%